Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In a rabbit model of Escherichia coli endocarditis, we studied the penetration into infected vegetations and the antibacterial effect of ceftriaxone. Ceftriaxone was given at different dosages, alone or with an interfering agent, diclofenac, a nonsteroidal anti-inflammatory drug, to determine the predictive value of the antibiotic levels in serum or infected vegetations on the antibacterial efficacy. Diclofenac increased the serum terminal half-life of ceftriaxone and increased its extravascular diffusion in tissue cage fluid, as well as in infected vegetations, allowing us to obtain various antibiotic concentrations in the infected site. Two hours after the fourth injection, around the time of peak level in serum, we observed a linear relationship between (i) serum and local antibiotic levels in vegetations, (ii) local antibiotic levels in a range of 142 to 600 X MBC and bacterial titer (log10 CFU/g) in vegetations, and (iii) serum antibiotic levels in a range of 800 to 1,400X MBC and bacterial titer in vegetations. In vivo, antibacterial effect was obtained only with high antibiotic levels in vegetations (greater than or equal to 220X MBC). This was confirmed by incubating vegetations sampled from infected animals in rabbit serum containing ceftriaxone (ex vivo experiment). Given once daily at a therapeutic dosage (30 mg/kg) for 4 days, ceftriaxone exhibited good efficacy (log10 CFU/g of vegetation = 2.41 +/- 2.7 versus 7.41 +/- 0.92 in control animals) and prevented regrowth of bacteria until 24 h after the last injection. We concluded that (i) provided the dose is sufficient, a long-acting cephalosporin can prove effective in severe gram-negative infections even when given infrequently, and (ii) serum antibiotic levels around the peak value, reflecting high effective local levels, could predict the therapeutic efficacy and represent a simple test to monitor the clinical course of a severe infectious process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bouvet, A., Cremieux, A. C., Contrepois, A., Vallois, J. M., Lamesch, C., & Carbon, C. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.28.5.607 · Cited by 52
Self-citation
Cited by
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
“Gram-negative bacteria do not adhere as well as gram-positive organisms, and induction of endocarditis in laboratory animals requires a much higher inoculum of gram-negative bacteria than of gram-positive organisms (96).”
BackgroundBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
Parsek, M. R., & Singh, P. K. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090720 · Cited by 1,562
Gould, F. K., Denning, D. W., Elliott, T. S. J., Foweraker, J., Perry, J. D., Prendergast, B. D., Sandoe, J. A. T., Spry, M. J., & Watkin, R. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr450 · Cited by 593
Bacterial adherence and biofilm formation on medical implants: A review
Veerachamy, S., Yarlagadda, T., Manivasagam, G., & Yarlagadda, P. K. (2014) · Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine · doi:10.1177/0954411914556137 · Cited by 583
Bacterial biofilms: a diagnostic and therapeutic challenge
Fux, C. A., Stoodley, P., Hall-Stoodley, L., & Costerton, J. W. (2003) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.1.4.667 · Cited by 269
Evaluation of Antibiotic Diffusion into Cardiac Vegetations by Quantitative Autoradiography
Cremieux, A.-C., Maziere, B., Vallois, J.-M., Ottaviani, M., Azancot, A., Raffoul, H., Bouvet, A., Pocidalo, J.-J., & Carbon, C. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.5.938 · Cited by 162
Self-citationReyes, M. P., & Reyes, K. C. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0044-5 · Cited by 33
Crémieux, A., Mazière, B., Vallois, J., Ottaviani, M., Bouvet, A., Pocidalo, J., & Carbon, C. (1991) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.1991.tb00701.x · Cited by 23
Self-citationCremieux, A. C., Saleh-Mghir, A., Vallois, J. M., Maziere, B., Muffat-Joly, M., Devine, C., Bouvet, A., Pocidalo, J. J., & Carbon, C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.10.2216 · Cited by 18
Self-citationPHARMACOKINETIC AND PHARMACODYNAMIC ASPECTS OF THERAPY OF EXPERIMENTAL ENDOCARDITIS
Carbon, C., Cremieux, A.-C., & Fantin, B. (1993) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(20)30504-3 · Cited by 14
Self-citation
Metadata
- Authors
- Joly, V, Pangon, B., Vallois, J. M., Abel, L., Brion, N., Bure, A., Chau, N. P., Contrepois, A., & Carbon, C.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1987-10
- Volume
- 31
- Issue
- 10
- Pages
- 1632-1639
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2076877186
- Cited by
- 64
- References
- 1
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.